Abstract
Background Pseudomonas aeruginosa (P. aeruginosa ) is an aerobic, gram negative, motile rod and possesses a variety of virulence factors. Antimicrobial resistance is an innate feature of bacterial biofilms.
Objectives Determination of prevalence, antibiotic susceptibility and biofilm production of P. aeruginosa isolates from clinical samples.
Materials and Methods A prospective study was carried out from the period of June 2014 to December 2014 in Microbiology Department, Dr. D. Y. Patil Medical College, Pune. The study included a total of 300 various clinical samples received in the department of Microbiology from different wards for routine culture and sensitivity test. The samples were processed and isolates were identified by standard protocol. All isolates were tested for phenotypic detection of biofilm formation and antibiotic resistance pattern.
Results Out of 300 clinical samples, 30 samples were positive for P. aeruginosa (10%). Maximum of 19 isolates were from pus/wound swab (63.33%) followed by urine 5 (20%). 23 (76.66%) were from males and 7 (23.33%) were from females. Maximum prevalence belonged to the age group of 41–60 years of age 14 (46.66%), followed by patients of 60–80 years of age 8 (26.66%). A total of 13 of the 30 isolates (43.33%) showed biofilm
production. 66.66% (10/15) of multiple antibiotic resistant isolates showed biofilm production. P. aeruginosa was highly resistant to ceftazidime 50% and least resistant to imipenem 10%.
Conclusion The results confirmed P. aeruginosa is a common pathogen isolated from various clinical samples of patients. In this study, the antibiotic resistance was significantly higher among biofilm-producing P. aeruginosa than non-producer. Imipenem was found to be the most effective antimicrobial agent. Use of ceftazidime should be restricted as it found least effective. To avoid rapid emergence of drug resistant strains, periodic testing of biofilm formation and antibiotic sensitivity should be carried out to detect the resistance trends. As this is a hospital-based epidemiological data, present study will help for implementation of better patient management and infection control strategies.
Keywords
References
Pathmanathan SG, Samat NA, Mohamed R. Antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa from a Malaysian hospital. Malays J Med Sci. 2009;16(2):28–33.
Deplano A, Denis O, Poirel L, Hocquet D, Nonhoff C, Byl B, et al. Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa. J Clin Microbiol. 2005;43:1198–1204.
Stover CK, Pham XQ, Erwin AL, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature. 2000;406:959–964.
Engel J, Balachandran P. Role of Pseudomonas aeruginosa type III effectors in disease. Curr Opin Microbiol. 2009;12:61–66.
Alous V, Navon-Venezia S, Seigman-Igra Y, Carmeli Y. Multidrugresistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2006;50(1):43–8.
Gad GF, EI-Domany RA, Zaki S, Ashour HM. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms. J Antimicrob Chemother. 2007;60(5):1010–7.
Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35: 322–332.
Dunne WM Jr. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev. 2002;15:155–660.
Potera C. Forging a link between biofilms and disease. Science. 1999;283:1837–1838.
Rajamohan G, Srinivasan VB, Gebreyes WA: Biocide-tolerant multidrug-resistant Acinetobacter baumannii clinical strains are associated with higher biofilm formation. J Hosp Infect. 2009;73:287–289.
Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167–93.
Sanchez CJ Jr, Mende K, Beckius ML, Akers KS, Romano DR, Wenke JC, et al. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis. 2013;13:47.
Rao RS, Karthika RU, Singh SP, Shashikala P, Kanungo R, Jayachandran S, et al. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumanii. Indian J Med Microbiol. 2008;26:333–7.
Bongo G, Granchino Y, Amicosante L, et al. Mechanisms of beta-actam resistance amongst Pseudomonas aeruginosa isolated in an Italian survey. J Antimicrob Chemother. 1998;42: 697–702.
Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 22nd informational supplement: M100-S22. Wayne: CLSI; 2012.
Christensen GD, Simpson WA, Bisno AL, Beachey EH. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982;37(1):318–326.
Dash M, Padhi S, Narasimham MV, Pattnaik S. Antimicrobial resistance pattern of Pseudomonas aeruginosa isolates from various clinical samples in a tertiary care hospital, South Odisha, India. Saudi J Health Sci. 2014;3:15–9.
Siham SAS, Hameed BH. Antibiotic resistant of Pseudomonas aeruginosa isolated from different clinical specimens. Kirkuk Univ J Sci Stud. 2014;9(2):15–28.
Rajat RM, Ninama GL, Mistry K, Parmar R, Patel K, Vegad MM. Antibiotic resistance pattern in Pseudomonas aeruginosa species isolated at a tertiary care Hospital, Ahmedabad. Nat J Med Res. 2012;2:156–9.
Javiya VA, Ghatak SB, Patel KR, Patel JA. Antibiotic susceptibility patterns of Pseudomonas aeruginosa at a tertiary care hospital in Gujarat, India. Indian J Pharmacol. 2008;40:230–4.
Srinivas B, Devi DI, Rao BN. A prospective study of Pseudomonas aeruginosa and its antibiogram in a teaching hospital of rural setup. J Pharm Biomed Sci. 2012;22:1–4.
Pathi B, Mishra SN, Panigrahi K, Poddar N, Lenka P, Mallick B. Prevalence and antibiogram pattern of Pseudomonas aeruginosa in a tertiary care hospital from Odisha, India. Transworld Med J. 2013;1(3):77–80.
Ahmed SM, Jakribettu RP, Kottakutty S, Arya B, Shakir VPA. An emerging multi-drug resistant pathogen in a tertiary care centre in North Kerala. Ann Biol Res. 2012;3(6):2794–99.
Raakhee T, Rao US. Prevalence and resistance pattern of Pseudomonas strains isolated from ICU patients. Int J Curr Microbiol Appl Sci. 2014;3(3):527–534.
Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit care Med. 2013:17:214–8.
Dardi CK, Wankhede SV. A study of biofilm formation and metallo-?-lactamase in Pseudomonas aruginosa in a tertiary care rural hospital. Int J Sci Res Pub. 2013;3.
Arora D, Jindal N, Romit KR. Emerging antibiotic resistance in Pseudomonas: a challenge. Int J Pharm Pharm Sci. 2011;3(2):82–84.
Refbacks
- There are currently no refbacks.
Copyright (c) 2016 Journal of Pharmaceutical and Biomedical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.